After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Alnylam Pharmaceuticals Inc is $36.55B. A total of 1.07 million shares were traded on the day, compared to an average of 745.17K shares.
In the most recent transaction, Garg Pushkal sold 5,445 shares of ALNY for 300.00 per share on Mar 24 ’25. After the transaction, the CMO & EVP Dev & Med Affairs now owns 20,221 company shares. In a previous transaction on Mar 21 ’25, Garg Pushkal sold 4,321 shares at 285.00 per share. ALNY shares that CMO & EVP Dev & Med Affairs owns now total 20,221.
Among the insiders who sold shares, PYOTT DAVID E I disposed of 7,440 shares on Mar 24 ’25 at a per-share price of $299.00. This resulted in the Director holding 136 shares of ALNY after the transaction. In another insider transaction, PYOTT DAVID E I bought 7,440 shares at $299.00 per share on Mar 24 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ALNY has a high of $304.39 and a low of $141.98.
As of this writing, ALNY has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.51 per share and a lower estimate of -$0.93.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ALNY’s latest balance sheet shows that the firm has $2.44B in Cash & Short Term Investments as of fiscal 2021. There were $997.59M in debt and $695.71M in liabilities at the time. Its Book Value Per Share was $0.52, while its Total Shareholder’s Equity was $588.20M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Buy with a score of 4.32.
